FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
2010 · Cancer Research · 233 citations
https://doi.org/10.1158/0008-5472.can-09-4120
S
Sanjay P. Bagaria
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
2.6K
Citations
30
h-index
55
i10-index
Sanjay P. Bagaria is an academic researcher from WinnMed. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Cutaneous Melanoma Detection and Management & Breast Cancer Treatment Studies. The author has an h-index of 30, co-authored 139 publications.
ORCID: 0000-0001-6677-8964Papers by this author
worksPersonalizing Breast Cancer Staging by the Inclusion of ER, PR, and HER2
2013 · JAMA Surgery · 98 citations
https://doi.org/10.1001/jamasurg.2013.3181
Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study
2011 · Annals of Surgical Oncology · 42 citations
https://doi.org/10.1245/s10434-011-1657-8
Rare Presentations of Primary Melanoma and Special Populations
2013 · American Journal of Clinical Oncology · 35 citations
https://doi.org/10.1097/coc.0b013e3182868e82
Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer
2011 · Annals of Surgical Oncology · 31 citations
https://doi.org/10.1245/s10434-011-2032-5
Compliance with guidelines in the surgical management of cutaneous melanoma across the USA
2013 · Melanoma Research · 25 citations
https://doi.org/10.1097/cmr.0b013e32836254bd
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat